Audit of tumour histopathology reviewed by a regional oncology centre.
Open Access
- 1 March 1995
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 48 (3) , 245-249
- https://doi.org/10.1136/jcp.48.3.245
Abstract
AIMS--To analyse the diagnostic differences in reporting tumour histopathology between a district general hospital and a regional oncology centre. METHODS--Tumour histopathology reports (n = 227) extracted from Bolton General Hospital files between 1988 and 1992 were compared with the corresponding Christie Hospital (oncology centre) reports, the same material having been seen at both hospitals. RESULTS--Diagnostic agreement existed in 77% of all cases. The incidence of major discrepancies was 8.37%. Of the diagnoses, 19 (36%) cases involved major discrepancies and 34 (64%) cases minor discrepancies. Most discrepancies occurred in the lymphoma group and involved subclassification of Hodgkin's and non-Hodgkin's lymphoma. Ki1 anaplastic large cell lymphoma and T cell rich B cell lymphoma were problematic diagnoses. The correct grading of follicle centre cell lymphomas using the Kiel classification was another problem area. In 19 cases certain aspects of immunohistochemistry produced discrepancies. In one case an incorrect diagnosis was made at the oncology centre and in another both centres gave an incorrect diagnosis. CONCLUSIONS--Areas of diagnostic difficulty mainly involve the subclassification of lymphomas. Review of tumour pathology by experts is recommended, at least in certain categories, to ensure correct diagnosis and uniformity in subclassification of tumours.Keywords
This publication has 7 references indexed in Scilit:
- Sarcomas in north west England: II IncidenceBritish Journal of Cancer, 1991
- Sarcomas in north west England: I. Histopathological peer reviewBritish Journal of Cancer, 1991
- The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cellsBlood, 1985
- THE EXPRESSION OF THE HODGKINS-DISEASE ASSOCIATED ANTIGEN-KI-1 IN REACTIVE AND NEOPLASTIC LYMPHOID-TISSUE - EVIDENCE THAT REED-STERNBERG CELLS AND HISTIOCYTIC MALIGNANCIES ARE DERIVED FROM ACTIVATED LYMPHOID-CELLS1985
- Quality assurance in surgical pathology--personal and peer assessment.1981
- Quality control and quality evaluation in histopathology and cytology.1973
- Observer disagreement in the classification and histology of Hodgkin's disease.1970